← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 19, 2022Last known activity
Mar 31, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (2 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Recent trials (9)
- NCT06272903Sponsor investigatorEarly Phase 1Mar 31, 2024
- NCT06272903Lead sponsorEarly Phase 1Mar 31, 2024
- NCT06272903OfficialEarly Phase 1Mar 31, 2024
- NCT06011005Lead sponsorN/ASep 1, 2023
- NCT06011005Overall official - principal investigatorN/ASep 1, 2023
- NCT06011005Reponsible party - principal investigatorN/ASep 1, 2023
- NCT05194007Reponsible party - principal investigatorPhase 2/Phase 3Feb 19, 2022
- NCT05194007Sponsor investigatorPhase 2/Phase 3Feb 19, 2022
- NCT05194007Lead sponsorPhase 2/Phase 3Feb 19, 2022
Details
- Last known activity
- Mar 31, 2024